课题基金 / 基金详情

Production of a novel resistant starches and evaluation of their human health benefits

Production of a novel resistant starches and evaluation of their human health benefits
新型抗性淀粉的生产及其对人类健康益处的评估
批准号:
336340-2006
负责人:
Emes, Michael
金额:
$9.09万
依托单位:
依托单位国家:
加拿大
项目类别:
Strategic Projects - Group
财政年份:
2007
资助国家:
加拿大
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31

项目摘要

项目成果

Emes, Michael的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aims of this proposal are to generate novel RSs through maize and barley breeding programs and evaluatetheir human health benefits following ingestion.Dietary and lifestyle-related diseases such as type-2 diabetes (T2DM), coronary heart disease, obesity andcolonic cancers are major causes of disability and premature death in westernised affluent societies andemerging nations. Increased consumption of whole grain cereal foods reduces the risk of these conditionssubstantially. In particular, resistant starch (RS) which is a component of dietary fibre makes an importantcontribution to these benefits by reducing rises in blood sugar levels following ingestion (helping to controlT2DM and reducing factors associated with cardiovascular disease) and acting as a prebiotic, promoting ahealthy lower gut microflora and mitigating incidents of colorectal cancer. RS intakes are low in populations athigh risk of the diseases of affluence, and there is a case for increasing its consumption as an effective means ofimproving nutrition for public health at the population level. Replacement of normal starches (which are themost important source of energy in the human diet) with RSs in daily consumed foods represents an idealopportunity to deliver profound health benefits to broad sectors of the population in an acceptable form.Physicochemical properties of RSs will be determined, and help determine their functionality as potential foodingredients by Maple Leaf Foods Inc. The RSs produced as a result of this program will also be used as avaluable source of research material to test hypotheses about the role of amyloplast protein complexes in theformation of RS structures. Overall, this comprehensive and multidisciplinary study of RS will create novelgermplasm, expand our knowledge in key areas of both human nutritional health and the regulation of storagestarch biosynthesis in plants, and contribute to the improvement of public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The regulation of starch biosynthesis and intermediary metabolism in plants
  • 批准号:
    RGPIN-2018-04789
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2022
  • 负责人:
    Emes, Michael
  • 依托单位:
The regulation of starch biosynthesis and intermediary metabolism in plants
  • 批准号:
    RGPIN-2018-04789
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2021
  • 负责人:
    Emes, Michael
  • 依托单位:
The regulation of starch biosynthesis and intermediary metabolism in plants
  • 批准号:
    RGPIN-2018-04789
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2020
  • 负责人:
    Emes, Michael
  • 依托单位:
The regulation of starch biosynthesis and intermediary metabolism in plants
  • 批准号:
    RGPIN-2018-04789
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2019
  • 负责人:
    Emes, Michael
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: